About Us
Science Programs
Pipeline
Clinical Trials
Careers
cONTACT
Resources
Corporate Presentation
Posters, PRESENTATIONS & Publications
MEDIA
Events
News & press releases
Investors
Overview
Stock Information
Analyst Coverage
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Financials & SEC FILINGS
Sec Filings
Quarterly Results
cORPORATE GOVERNANCE
Management Team
Board of Directors
Committee Composition
Governance Documents
News & Press Releases
Get up to speed with Rain!
Filter by year...
2022
2021
2020
2019
2018
Reset Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November
4
,
2022
Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)
Download PDf
October
27
,
2022
Rain Therapeutics to Report Third Quarter 2022 Financial Results and Highlights of Recent Progress on November 10, 2022
Download PDf
October
26
,
2022
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
Download PDf
August
31
,
2022
Rain Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference
Download PDf
August
4
,
2022
Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
Download PDf
August
4
,
2022
Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma
Download PDf
July
21
,
2022
Rain Therapeutics to Report Second Quarter 2022 Financial Results and Highlights of Recent Progress on August 4, 2022
Download PDf
May
18
,
2022
Rain Therapeutics to Present on Milademetan at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Download PDf
May
4
,
2022
Rain Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Progress
Download PDf
April
20
,
2022
Rain Therapeutics to Report First Quarter 2022 Financial Results and Highlights of Recent Progress on May 4, 2022
Download PDf
Previous
#
Next
